More specifically, it was reported that IL-13 is produced by malignant lymphoma cells and acts as an autocrine factor regulating tumor cell proliferation through IL-13R signaling in both CTCL skin lesions and SCs in blood [42]. This evidence concerns the gene IL13 and primary cutaneous T-cell non-Hodgkin lymphoma.